BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun XQ, Abbate A, Bogaard HJ. Role of cardiac inflammation in right ventricular failure. Cardiovasc Res 2017;113:1441-52. [PMID: 28957536 DOI: 10.1093/cvr/cvx159] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Younes R, Leblanc C, Hiram R. Evidence of Failed Resolution Mechanisms in Arrhythmogenic Inflammation, Fibrosis and Right Heart Disease. Biomolecules 2022;12:720. [DOI: 10.3390/biom12050720] [Reference Citation Analysis]
2 King NE, Brittain E. Emerging therapies: The potential roles SGLT2 inhibitors, GLP1 agonists, and ARNI therapy for ARNI pulmonary hypertension. Pulm circ 2022;12. [DOI: 10.1002/pul2.12028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Guo L, Qin G, Cao Y, Yang Y, Dai S, Wang L, Wang E. Regulation of the Immune Microenvironment by an NLRP3 Inhibitor Contributes to Attenuation of Acute Right Ventricular Failure in Rats with Pulmonary Arterial Hypertension. J Inflamm Res 2021;14:5699-711. [PMID: 34754216 DOI: 10.2147/JIR.S336964] [Reference Citation Analysis]
4 Wang R, Xu J, Wu J, Gao S, Wang Z. Angiotensin-converting enzyme 2 alleviates pulmonary artery hypertension through inhibition of focal adhesion kinase expression. Exp Ther Med 2021;22:1165. [PMID: 34504610 DOI: 10.3892/etm.2021.10599] [Reference Citation Analysis]
5 Bernal-Ramirez J, Díaz-Vesga MC, Talamilla M, Méndez A, Quiroga C, Garza-Cervantes JA, Lázaro-Alfaro A, Jerjes-Sanchez C, Henríquez M, García-Rivas G, Pedrozo Z. Exploring Functional Differences between the Right and Left Ventricles to Better Understand Right Ventricular Dysfunction. Oxid Med Cell Longev 2021;2021:9993060. [PMID: 34497685 DOI: 10.1155/2021/9993060] [Reference Citation Analysis]
6 Ząbczyk M, Natorska J, Janion-Sadowska A, Metzgier-Gumiela A, Polak M, Plens K, Janion M, Skonieczny G, Mizia-Stec K, Undas A. Isoprostane-8 and GDF-15 as novel markers of post-PE syndrome: Relation with prothrombotic factors. Eur J Clin Invest 2021;:e13660. [PMID: 34312860 DOI: 10.1111/eci.13660] [Reference Citation Analysis]
7 Montagnoli TL, da Silva JS, Sudo SZ, Santos AD, Gomide GF, de Sá MPL, Zapata-Sudo G. ROCK Inhibition as Potential Target for Treatment of Pulmonary Hypertension. Cells 2021;10:1648. [PMID: 34209333 DOI: 10.3390/cells10071648] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hautbergue T, Antigny F, Boët A, Haddad F, Masson B, Lambert M, Delaporte A, Menager JB, Savale L, Pavec JL, Fadel E, Humbert M, Junot C, Fenaille F, Colsch B, Mercier O. Right Ventricle Remodeling Metabolic Signature in Experimental Pulmonary Hypertension Models of Chronic Hypoxia and Monocrotaline Exposure. Cells 2021;10:1559. [PMID: 34205639 DOI: 10.3390/cells10061559] [Reference Citation Analysis]
9 Rajabi S, Najafipour H, Jafarinejad-Farsangi S, Joukar S, Beik A, Askaripour M, Jafari E, Safi Z. Quercetin, Perillyl Alcohol, and Berberine Ameliorate Right Ventricular Disorders in Experimental Pulmonary Arterial Hypertension: Effects on miR-204, miR-27a, Fibrotic, Apoptotic, and Inflammatory Factors. J Cardiovasc Pharmacol 2021;77:777-86. [PMID: 34016844 DOI: 10.1097/FJC.0000000000001015] [Reference Citation Analysis]
10 Nishizaki M, Ogawa A, Matsubara H. High Right Ventricular Afterload during Exercise in Patients with Pulmonary Arterial Hypertension. J Clin Med 2021;10:2024. [PMID: 34065097 DOI: 10.3390/jcm10092024] [Reference Citation Analysis]
11 Stam K, Clauss S, Taverne YJHJ, Merkus D. Chronic Thromboembolic Pulmonary Hypertension - What Have We Learned From Large Animal Models. Front Cardiovasc Med 2021;8:574360. [PMID: 33937352 DOI: 10.3389/fcvm.2021.574360] [Reference Citation Analysis]
12 Cruz MS, da Silva AMG, de Souza KSC, Luchessi AD, Silbiger VN. miRNAs emerge as circulating biomarkers of post-myocardial infarction heart failure. Heart Fail Rev 2020;25:321-9. [PMID: 31254148 DOI: 10.1007/s10741-019-09821-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
13 King PM, Raymer DS, Shuster J, Crain M, Bhatia A, Hartupee J, Schilling JD. Right Heart Failure While on Left Ventricular Assist Device Support Is Associated with Primary Graft Dysfunction. ASAIO J 2020;66:1137-41. [PMID: 33136601 DOI: 10.1097/MAT.0000000000001156] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 van Uden D, Koudstaal T, van Hulst JAC, Bergen IM, Gootjes C, Morrell NW, van Loo G, von der Thüsen JH, van den Bosch TPP, Ghigna MR, Perros F, Montani D, Kool M, Boomars KA, Hendriks RW. Central Role of Dendritic Cells in Pulmonary Arterial Hypertension in Human and Mice. Int J Mol Sci 2021;22:1756. [PMID: 33578743 DOI: 10.3390/ijms22041756] [Reference Citation Analysis]
15 Llucià-Valldeperas A, de Man FS, Bogaard HJ. Adaptation and Maladaptation of the Right Ventricle in Pulmonary Vascular Diseases. Clin Chest Med 2021;42:179-94. [PMID: 33541611 DOI: 10.1016/j.ccm.2020.11.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Denning NL, Aziz M, Diao L, Prince JM, Wang P. Targeting the eCIRP/TREM-1 interaction with a small molecule inhibitor improves cardiac dysfunction in neonatal sepsis. Mol Med 2020;26:121. [PMID: 33276725 DOI: 10.1186/s10020-020-00243-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Sydykov A, Luitel H, Mamazhakypov A, Wygrecka M, Pradhan K, Pak O, Petrovic A, Kojonazarov B, Weissmann N, Seeger W, Grimminger F, Ghofrani HA, Kosanovic D, Schermuly RT. Genetic Deficiency and Pharmacological Stabilization of Mast Cells Ameliorate Pressure Overload-Induced Maladaptive Right Ventricular Remodeling in Mice. Int J Mol Sci 2020;21:E9099. [PMID: 33265921 DOI: 10.3390/ijms21239099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Kim H, Yoo J, Lim YM, Kim EJ, Yoon BI, Kim P, Yu SD, Eom IC, Shim I. Comprehensive pulmonary toxicity assessment of cetylpyridinium chloride using A549 cells and Sprague-Dawley rats. J Appl Toxicol 2021;41:470-82. [PMID: 33022792 DOI: 10.1002/jat.4058] [Reference Citation Analysis]
19 Taverne YJHJ, Sadeghi A, Bartelds B, Bogers AJJC, Merkus D. Right ventricular phenotype, function, and failure: a journey from evolution to clinics. Heart Fail Rev 2020. [PMID: 32556672 DOI: 10.1007/s10741-020-09982-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Groeneveldt JA, de Man FS, Westerhof BE. The right treatment for the right ventricle. Curr Opin Pulm Med 2019;25:410-7. [PMID: 31365374 DOI: 10.1097/MCP.0000000000000610] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
21 Antigny F, Mercier O, Humbert M, Sabourin J. Excitation-contraction coupling and relaxation alteration in right ventricular remodelling caused by pulmonary arterial hypertension. Archives of Cardiovascular Diseases 2020;113:70-84. [DOI: 10.1016/j.acvd.2019.10.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
22 Boehm M, Novoyatleva T, Kojonazarov B, Veit F, Weissmann N, Ghofrani HA, Seeger W, Schermuly RT. Nitric Oxide Synthase 2 Induction Promotes Right Ventricular Fibrosis. Am J Respir Cell Mol Biol 2019;60:346-56. [PMID: 30277804 DOI: 10.1165/rcmb.2018-0069OC] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
23 Ntiloudi D, Qanud K, Tomaio JN, Giannakoulas G, Al-Abed Y, Zanos S. Pulmonary arterial hypertension: the case for a bioelectronic treatment. Bioelectron Med 2019;5:20. [PMID: 32232109 DOI: 10.1186/s42234-019-0036-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
24 Small HY, Guzik TJ. High impact Cardiovascular Research: beyond the heart and vessels. Cardiovasc Res 2019;115:e166-71. [PMID: 31697316 DOI: 10.1093/cvr/cvz272] [Reference Citation Analysis]
25 Axelsen JB, Andersen S, Sun XQ, Ringgaard S, Hyldebrandt JA, Kurakula K, Goumans MJ, de Man FS, Nielsen-Kudsk JE, Bogaard HJ, Andersen A. Effects of 6-mercaptopurine in pressure overload induced right heart failure. PLoS One 2019;14:e0225122. [PMID: 31714926 DOI: 10.1371/journal.pone.0225122] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
26 Sagan A, Mikolajczyk TP, Mrowiecki W, MacRitchie N, Daly K, Meldrum A, Migliarino S, Delles C, Urbanski K, Filip G, Kapelak B, Maffia P, Touyz R, Guzik TJ. T Cells Are Dominant Population in Human Abdominal Aortic Aneurysms and Their Infiltration in the Perivascular Tissue Correlates With Disease Severity. Front Immunol 2019;10:1979. [PMID: 31552015 DOI: 10.3389/fimmu.2019.01979] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
27 Strassheim D, Dempsey EC, Gerasimovskaya E, Stenmark K, Karoor V. Role of Inflammatory Cell Subtypes in Heart Failure. J Immunol Res 2019;2019:2164017. [PMID: 31565659 DOI: 10.1155/2019/2164017] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
28 Kajimoto M, Nuri M, Isern NG, Robillard-Frayne I, Des Rosiers C, Portman MA. Metabolic Response to Stress by the Immature Right Ventricle Exposed to Chronic Pressure Overload. J Am Heart Assoc 2019;8:e013169. [PMID: 31450994 DOI: 10.1161/JAHA.119.013169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
29 Stam K, Cai Z, van der Velde N, van Duin R, Lam E, van der Velden J, Hirsch A, Duncker DJ, Merkus D. Cardiac remodelling in a swine model of chronic thromboembolic pulmonary hypertension: comparison of right vs. left ventricle. J Physiol 2019;597:4465-80. [PMID: 31194256 DOI: 10.1113/JP277896] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
30 Katsimichas T, Antonopoulos AS, Katsimichas A, Ohtani T, Sakata Y, Tousoulis D. The intestinal microbiota and cardiovascular disease. Cardiovascular Research 2019;115:1471-86. [DOI: 10.1093/cvr/cvz135] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
31 Zelt JG, Chaudhary KR, Cadete VJ, Mielniczuk LM, Stewart DJ. Medical Therapy for Heart Failure Associated With Pulmonary Hypertension. Circ Res 2019;124:1551-67. [DOI: 10.1161/circresaha.118.313650] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
32 Ren X, Johns RA, Gao WD. EXPRESS: Right Heart in Pulmonary Hypertension: From Adaptation to Failure. Pulm Circ 2019;:2045894019845611. [PMID: 30942134 DOI: 10.1177/2045894019845611] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
33 Sanz J, Sánchez-quintana D, Bossone E, Bogaard HJ, Naeije R. Anatomy, Function, and Dysfunction of the Right Ventricle. Journal of the American College of Cardiology 2019;73:1463-82. [DOI: 10.1016/j.jacc.2018.12.076] [Cited by in Crossref: 132] [Cited by in F6Publishing: 109] [Article Influence: 44.0] [Reference Citation Analysis]
34 Atzler D, de Winther MPJ. DARC matter(s) for inflammatory cells. Cardiovasc Res 2018;114:e11-3. [PMID: 29373721 DOI: 10.1093/cvr/cvx230] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
35 . The Obesity Paradox in Cardiovascular Diseases. Journal of Clinical Exercise Physiology 2019;8:30-53. [DOI: 10.31189/2165-6193-8.1.30] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
36 Ma S, Wang X, Yao J, Cao Q, Zuo X. Roles of apoptosis and inflammation in a rat model of acute lung injury induced right ventricular dysfunction. Biomed Pharmacother 2018;108:1105-14. [PMID: 30372811 DOI: 10.1016/j.biopha.2018.09.115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Proniewski B, Czarny J, Khomich TI, Kus K, Zakrzewska A, Chlopicki S. Immuno-Spin Trapping-Based Detection of Oxidative Modifications in Cardiomyocytes and Coronary Endothelium in the Progression of Heart Failure in Tgαq*44 Mice. Front Immunol 2018;9:938. [PMID: 29867936 DOI: 10.3389/fimmu.2018.00938] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
38 Sabourin J, Boet A, Rucker-Martin C, Lambert M, Gomez AM, Benitah JP, Perros F, Humbert M, Antigny F. Ca2+ handling remodeling and STIM1L/Orai1/TRPC1/TRPC4 upregulation in monocrotaline-induced right ventricular hypertrophy. J Mol Cell Cardiol 2018;118:208-24. [PMID: 29634917 DOI: 10.1016/j.yjmcc.2018.04.003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 8.3] [Reference Citation Analysis]
39 Oikonomou EK. Clinical and translational science in cardiovascular research: highlights from the American Heart Association Scientific Sessions 2017: Changing view on the concept of cardiovascular risk and blood pressure targets. Cardiovasc Res 2018;114:e6-8. [PMID: 29202178 DOI: 10.1093/cvr/cvx233] [Reference Citation Analysis]